WallStreetZenWallStreetZen

NASDAQ: BRTX
Biorestorative Therapies Inc Stock

$1.39-0.01 (-0.71%)
Updated Mar 27, 2024
BRTX Price
$1.39
Fair Value Price
$0.36
Market Cap
$6.56M
52 Week Low
$1.20
52 Week High
$7.13
P/E
-0.34x
P/B
0.51x
P/S
62.84x
PEG
N/A
Dividend Yield
N/A
Revenue
$130.20k
Earnings
-$15.94M
Gross Margin
100%
Operating Margin
-12,465.44%
Profit Margin
-12,241%
Debt to Equity
0.08
Operating Cash Flow
-$6M
Beta
-0.45
Next Earnings
May 12, 2024
Ex-Dividend
N/A
Next Dividend
N/A

BRTX Overview

BioRestorative Therapies Inc is a biotechnology company developing therapies using cell and tissue protocols, mostly involving non-embryonic stem cells. The company's Disc/Spine Program includesBRTX-100, a cell therapy candidate formulated from stem cells collected from the patient's bone marrow. Its Metabolic Program is developing a cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells. BioRestorative Therapies was founded in 1997 and is headquartered in Melville, New York.

Zen Score

–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BRTX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BRTX ($1.39) is overvalued by 285.89% relative to our estimate of its Fair Value price of $0.36 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
BRTX ($1.39) is not significantly undervalued (285.89%) relative to our estimate of its Fair Value price of $0.36 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
BRTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more BRTX due diligence checks available for Premium users.

Be the first to know about important BRTX news, forecast changes, insider trades & much more!

BRTX News

Valuation

BRTX fair value

Fair Value of BRTX stock based on Discounted Cash Flow (DCF)
Price
$1.39
Fair Value
$0.36
Overvalued by
285.06%
BRTX ($1.39) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BRTX ($1.39) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BRTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BRTX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.34x
Industry
14.3x
Market
44.45x

BRTX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.51x
Industry
6.2x
BRTX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BRTX's financial health

Profit margin

Revenue
$30.7k
Net Income
-$2.9M
Profit Margin
-9,529.3%
BRTX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
BRTX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$13.8M
Liabilities
$975.0k
Debt to equity
0.08
BRTX's short-term assets ($12.60M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BRTX's short-term assets ($12.60M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BRTX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BRTX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.2M
Investing
-$23.1k
Financing
$1.9M
BRTX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

BRTX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
BRTX$6.56M-0.50%-0.34x0.51x
VCNX$6.65M-1.32%-0.09x-1.72x
SNGX$6.39M+2.88%-0.77x2.53x
ATXI$6.77M+1.32%-0.16x4.28x
SONN$6.23M-0.25%-0.21x2.42x

Biorestorative Therapies Stock FAQ

What is Biorestorative Therapies's quote symbol?

(NASDAQ: BRTX) Biorestorative Therapies trades on the NASDAQ under the ticker symbol BRTX. Biorestorative Therapies stock quotes can also be displayed as NASDAQ: BRTX.

If you're new to stock investing, here's how to buy Biorestorative Therapies stock.

What is the 52 week high and low for Biorestorative Therapies (NASDAQ: BRTX)?

(NASDAQ: BRTX) Biorestorative Therapies's 52-week high was $7.13, and its 52-week low was $1.20. It is currently -80.46% from its 52-week high and 16.08% from its 52-week low.

How much is Biorestorative Therapies stock worth today?

(NASDAQ: BRTX) Biorestorative Therapies currently has 4,706,917 outstanding shares. With Biorestorative Therapies stock trading at $1.39 per share, the total value of Biorestorative Therapies stock (market capitalization) is $6.56M.

Biorestorative Therapies stock was originally listed at a price of $32.00 in Dec 5, 2012. If you had invested in Biorestorative Therapies stock at $32.00, your return over the last 11 years would have been -95.65%, for an annualized return of -24.79% (not including any dividends or dividend reinvestments).

How much is Biorestorative Therapies's stock price per share?

(NASDAQ: BRTX) Biorestorative Therapies stock price per share is $1.39 today (as of Mar 27, 2024).

What is Biorestorative Therapies's Market Cap?

(NASDAQ: BRTX) Biorestorative Therapies's market cap is $6.56M, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Biorestorative Therapies's market cap is calculated by multiplying BRTX's current stock price of $1.39 by BRTX's total outstanding shares of 4,706,917.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.